Biovian Oy
  1. Companies
  2. Biovian Oy
  3. Services
  4. Viral Vector GMP Production Facility ...

Viral Vector GMP Production Facility Service

SHARE

The state-of-the-art production facility allows for flexible viral vector production scenarios. The cleanroom class C (EU GMP) and biosafety level 2 facility is designed for the manufacturing of GMP-grade viral vectors. The space design follows a modular ballroom concept and unidirectional process flow. The equipment are mobile, allowing for easy reconfiguring, and the operations are performed according to one-way process principles from incoming to outgoing material. Production is campaign-based – a single product is produced at a time, and disposable materials and closed systems are used. Open processes are executed in biosafety cabinets with HEPA 14 filters, with air exhaust directly out of the building.

Most popular related searches

Utilities

  • The production area is equipped with HVAC technology with a single-pass ventilation design, without any recirculation of air.
  • The facility includes a restricted passage with electronic access control and pressured air-locks for material and personnel entry and exit. The air-locks are composed of two-parts (D- and C-grade) and controlled with inter-locks. HEPA filters are placed across the operating area and air-locks.
  • Other utilities include gas supplies (CO2, O2, N2) and compressed air outlets.
  • The facility is equipped with 24/7 monitoring and an alarm system.

Track record in viral vector development and manufacturing

  • Biovian has been developing viral vector processes since 2004.
  • Over 40 clinical GMP batches have been manufactured, including batches for clinical phases up to Phase III as well as commercial validation batches.
  • Longest-lasting customer relationship >10 years and still active.

Cell Banks and Virus Seed Stocks

  • Research Cell Bank
  • Master Cell Bank and Working Cell Bank
  • Master Viral Seed Stock and Working Seed Stock

Upstream Processes

  • Suspension Cell Culture in single-use bioreactors – up to 200 L
  • Adherent Cell Culture in multilayer flasks, packed-bed bioreactor and single-use bioreactors on microcarriers

Downstream Processes

  • Ultracentrifugation-based Downstream Processes
  • Chromatography-based Downstream Processes
  • Comprehensive purification solutions – chromatography, membrane processes, Tangential Flow Filtration processes (TFF)

Aseptic Fill and Finish

  • Formulation and final Drug Product manufacturing
  • Automated Aseptic Filling line for live Viral Vectors
  • Typical batch sizes 200 – 1000 vials

Quality Assurance and Quality Control

  • Product-specific assays
  • Impurity analysis
  • Cell-based assays
  • Microbiological QC and safety assays (sterility, bioburden, endotoxin etc.)
  • QP Certification and full GMP documentation